Galmed Pharmaceuticals Holds Annual Shareholder Meeting
Ticker: GLMD · Form: 6-K · Filed: Oct 29, 2025 · CIK: 1595353
| Field | Detail |
|---|---|
| Company | Galmed Pharmaceuticals LTD. (GLMD) |
| Form Type | 6-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Galmed Pharma held its shareholder meeting on Oct 29, voted on proxy items.
AI Summary
On October 29, 2025, Galmed Pharmaceuticals Ltd. held its Annual General Meeting of Shareholders. Shareholders voted on proposals previously outlined in the company's proxy statement filed on September 19, 2025. The specific outcomes of these votes were not detailed in this filing.
Why It Matters
This filing confirms the holding of the annual shareholder meeting, a routine corporate governance event where shareholders exercise their voting rights on company matters.
Risk Assessment
Risk Level: low — This filing is a routine update on a shareholder meeting and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Galmed Pharmaceuticals Ltd. (company) — Registrant
- October 29, 2025 (date) — Date of Annual General Meeting
- September 19, 2025 (date) — Date of proxy statement filing
FAQ
What was the purpose of the Form 6-K filing?
The Form 6-K filing was to report on the Annual General Meeting of Shareholders held by Galmed Pharmaceuticals Ltd. on October 29, 2025.
When was the Annual General Meeting of Shareholders held?
The Annual General Meeting of Shareholders was held on October 29, 2025.
What proposals were voted on at the meeting?
Shareholders voted on all proposals described in the proxy statement for the meeting, which was filed on September 19, 2025.
Where is Galmed Pharmaceuticals Ltd. located?
Galmed Pharmaceuticals Ltd.'s principal executive offices are located at c/o Meitar Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan, 5250608.
Does Galmed Pharmaceuticals Ltd. file annual reports under Form 20-F or 40-F?
Galmed Pharmaceuticals Ltd. indicates that it files annual reports under Form 20-F.
Filing Stats: 270 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2025-10-29 16:05:17
Filing Documents
- form6-k.htm (6-K) — 15KB
- 0001493152-25-020057.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Galmed Pharmaceuticals Ltd. Date: October 29, 2025 By: /s/ Allen Baharaff Allen Baharaff President and Chief Executive Officer